hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){...
-
Upload
alfredo-nichols -
Category
Documents
-
view
217 -
download
0
Transcript of hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){...
![Page 1: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/1.jpg)
HEMOLYTIC ANEMIAS
![Page 2: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/2.jpg)
HEMOLYTIC ANEMIA• Anemia of increased destruction
– Normochromic, normochromic anemia
– Shortened RBC survival– Reticulocytosis - Response to
increased RBC destruction– Increased indirect bilirubin– Increased LDH
![Page 3: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/3.jpg)
HEMOLYTIC ANEMIATesting
• Absent haptoglobin• Hemoglobinuria• Hemoglobinemia
![Page 4: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/4.jpg)
![Page 5: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/5.jpg)
HEMOLYTIC ANEMIACauses
• INTRACORPUSCULAR HEMOLYSIS– Membrane Abnormalities– Metabolic Abnormalities– Hemoglobinopathies
• EXTRACORPUSCULAR HEMOLYSIS– Nonimmune – Immune
![Page 6: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/6.jpg)
HEMOLYTIC ANEMIAMembrane Defects
• Microskeletal defects– Hereditary spherocytosis
• Membrane permeability defects– Hereditary stomatocytosis
• Increased sensitivity to complement– Paroxysmal nocturnal hemoglobinuria
![Page 7: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/7.jpg)
RED CELL CYTOSKELETON
![Page 8: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/8.jpg)
HEREDITARY SPHEROCYTOSIS• Defective or absent spectrin
molecule• Leads to loss of RBC membrane,
leading to spherocytosis• Decreased deformability of cell• Increased osmotic fragility• Extravascular hemolysis in spleen
![Page 9: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/9.jpg)
![Page 10: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/10.jpg)
SPLENIC ARCHITECTURE
![Page 11: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/11.jpg)
HEREDITARY SPHEROCYTOSISOsmotic Fragility
0
20
40
60
80
100
0.3 0.4 0.5 0.6
NaCl (% of normal saline)
% H
emol
ysis
Normal HS
![Page 12: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/12.jpg)
Paroxysmal Nocturnal Hemoglobinuria
• Clonal cell disorder• Ongoing Intra- & Extravascular
hemolysis; classically at night• Testing
– Acid hemolysis (Ham test)– Sucrose hemolysis– CD-59 negative (Product of PIG-A gene)
• Acquired deficit of GPI-Associated proteins (including Decay Activating Factor)
![Page 13: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/13.jpg)
![Page 14: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/14.jpg)
GPI BRIDGE
![Page 15: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/15.jpg)
Paroxysmal Nocturnal Hemoglobinuria
GPI Proteins• GPI links a series of proteins to outer leaf
of cell membrane via phosphatidyl inositol bridge, with membrane anchor via diacylglycerol bridge
• PIG-A gene, on X-chromosome, codes for synthesis of this bridge; multiple defects known to cause lack of this bridge
• Absence of decay accelerating factor leads to failure to inactivate complement & thereby to increased cell lysis
![Page 16: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/16.jpg)
HEMOLYTIC ANEMIAMembrane abnormalities - Enzymopathies
• Deficiencies in Hexose Monophosphate Shunt– Glucose 6-Phosphate Dehydrogenase
Deficiency• Deficiencies in the EM Pathway
– Pyruvate Kinase Deficiency
![Page 17: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/17.jpg)
G6PD DEFICIENCYFunction of G6PD
G6PD
GSSG 2 GSH
NADPH NADP
2 H2O H2O2
6-PG G6P
Hgb
Sulf-Hgb
Heinz bodies
Hemolysis
InfectionsDrugs
![Page 18: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/18.jpg)
Glucose 6-Phosphate Dehydrogenase
Functions
• Regenerates NADPH, allowing regeneration of glutathione
• Protects against oxidative stress• Lack of G6PD leads to hemolysis during
oxidative stress– Infection– Medications– Fava beans
• Oxidative stress leads to Heinz body formation, extravascular hemolysis
![Page 19: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/19.jpg)
Glucose 6-Phosphate DehydrogenaseDifferent Isozymes
00.20.40.60.8
1
0 20 40 60 80 100 120
RBC Age (Days)
G6P
D A
ctiv
ity (%
)
Normal (GdB) Black Variant (GdA-)Mediterranean (Gd Med)
Level needed for protection vs ordinary oxidative stress
![Page 20: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/20.jpg)
![Page 21: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/21.jpg)
HEMOLYTIC ANEMIACauses
• INTRACORPUSCULAR HEMOLYSIS– Membrane Abnormalities– Metabolic Abnormalities– Hemoglobinopathies
• EXTRACORPUSCULAR HEMOLYSIS– Nonimmune – Immune
![Page 22: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/22.jpg)
EXTRACORPUSCULAR HEMOLYSIS
Nonimmune
• Mechanical• Infectious• Chemical• Thermal• Osmotic
![Page 23: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/23.jpg)
Microangiopathic Hemolytic AnemiaCauses
• Vascular abnormalities– Thrombotic thrombocytopenic purpura– Renal lesions
• Malignant hypertension• Glomerulonephritis• Preeclampsia• Transplant rejection
– Vasculitis• Polyarteritis nodosa• Rocky mountain spotted fever• Wegener’s granulomatosis
![Page 24: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/24.jpg)
Microangiopathic Hemolytic Anemia
Causes - #2
– Vascular abnormalities• AV Fistula• Cavernous hemangioma
• Intravascular coagulation predominant– Abruptio placentae– Disseminated intravascular
coagulation
![Page 25: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/25.jpg)
![Page 26: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/26.jpg)
IMMUNE HEMOLYTIC ANEMIAGeneral Principles
• All require antigen-antibody reactions• Types of reactions dependent on:
– Class of Antibody– Number & Spacing of antigenic sites on cell– Availability of complement– Environmental Temperature– Functional status of reticuloendothelial system
• Manifestations– Intravascular hemolysis– Extravascular hemolysis
![Page 27: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/27.jpg)
IMMUNE HEMOLYTIC ANEMIAGeneral Principles - 2
• Antibodies combine with RBC, & either1. Activate complement cascade, &/or2. Opsonize RBC for immune system
• If 1, if all of complement cascade is fixed to red cell, intravascular cell lysis occurs
• If 2, &/or if complement is only partially fixed, macrophages recognize Fc receptor of Ig &/or C3b of complement & phagocytize RBC, causing extravascular RBC destruction
![Page 28: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/28.jpg)
IMMUNE HEMOLYTIC ANEMIACoombs Test - Direct
• Looks for immunoglobulin &/or complement of surface of red blood cell (normally neither found on RBC surface)
• Coombs reagent - combination of anti-human immunoglobulin & anti-human complement
• Mixed with patient’s red cells; if immunoglobulin or complement are on surface, Coombs reagent will link cells together and cause agglutination of RBCs
![Page 29: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/29.jpg)
IMMUNE HEMOLYTIC ANEMIACoombs Test - Indirect
• Looks for anti-red blood cell antibodies in the patient’s serum, using a panel of red cells with known surface antigens
• Combine patient’s serum with cells from a panel of RBC’s with known antigens
• Add Coombs’ reagent to this mixture• If anti-RBC antigens are in serum,
agglutination occurs
![Page 30: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/30.jpg)
HEMOLYTIC ANEMIA - IMMUNE• Drug-Related Hemolysis• Alloimmune Hemolysis
– Hemolytic Transfusion Reaction – Hemolytic Disease of the Newborn
• Autoimmune Hemolysis– Warm autoimmune hemolysis– Cold autoimmune hemolysis
![Page 31: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/31.jpg)
IMMUNE HEMOLYSISDrug-Related
• Immune Complex Mechanism– Quinidine, Quinine, Isoniazid
• “Haptenic” Immune Mechanism– Penicillins, Cephalosporins
• True Autoimmune Mechanism– Methyldopa, L-DOPA, Procaineamide,
Ibuprofen
![Page 32: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/32.jpg)
DRUG-INDUCED HEMOLYSISImmune Complex Mechanism
• Drug & antibody bind in the plasma• Immune complexes either
– Activate complement in the plasma, or– Sit on red blood cell
• Antigen-antibody complex recognized by RE system
• Red cells lysed as “innocent bystander” of destruction of immune complex
• REQUIRES DRUG IN SYSTEM
![Page 33: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/33.jpg)
DRUG-INDUCED HEMOLYSISHaptenic Mechanism
• Drug binds to & reacts with red cell surface proteins
• Antibodies recognize altered protein, ± drug, as foreign
• Antibodies bind to altered protein & initiate process leading to hemolysis
![Page 34: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/34.jpg)
DRUG-INDUCED HEMOLYSISTrue Autoantibody Formation
• Certain drugs appear to cause antibodies that react with antigens normally found on RBC surface, and do so even in the absence of the drug
![Page 35: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/35.jpg)
ALLOIMUNE HEMOLYSISHemolytic Transfusion Reaction
• Caused by recognition of foreign antigens on transfused blood cells
• Several types– Immediate Intravascular Hemolysis (Minutes) -
Due to preformed antibodies; life-threatening– Slow extravascular hemolysis (Days) - Usually due
to repeat exposure to a foreign antigen to which there was a previous exposure; usually only mild symptoms
– Delayed sensitization - (Weeks) - Usually due to 1st exposure to foreign antigen; asymptomatic
![Page 36: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/36.jpg)
INCOMPATIBLE RBC TRANSFUSIONRate of Hemolysis
0
20
40
60
80
100
0 1 2 3 4 5 6 7Weeks Post-Transfusion
Surv
ivin
g C
ells
(%)
Normal Immediate Intravascular HemolysisSlow Extravascular Hemolysis Delayed Extravascular Hemolysis
![Page 37: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/37.jpg)
ALLOIMMUNE HEMOLYSISTesting Pre-transfusion
• ABO & Rh Type of both donor & recipient
• Antibody Screen of Donor & Recipient, including indirect Coombs
• Major cross-match by same procedure (recipient serum & donor red cells)
![Page 38: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/38.jpg)
ALLOIMMUNE HEMOLYSISHemolytic Disease of the Newborn
• Due to incompatibility between mother negative for an antigen & fetus/father positive for that antigen. Rh incompatibility, ABO incompatibility most common causes
• Usually occurs with 2nd or later pregnancies
• Requires maternal IgG antibodies vs. RBC antigens in fetus
![Page 39: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/39.jpg)
ALLOIMMUNE HEMOLYSISHemolytic Disease of the Newborn - #2
• Can cause severe anemia in fetus, with erythroblastosis and heart failure
• Hyperbilirubinemia can lead to severe brain damage (kernicterus) if not promptly treated
• HDN due to Rh incompatibility can be almost totally prevented by administration of anti-Rh D to Rh negative mothers after each pregnancy
![Page 40: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/40.jpg)
AUTOIMMUNE HEMOLYSIS• Due to formation of autoantibodies
that attack patient’s own RBC’s• Type characterized by ability of
autoantibodies to fix complement & site of RBC destruction
• Often associated with either lymphoproliferative disease or collagen vascular disease
![Page 41: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/41.jpg)
AUTOIMMUNE HEMOLYSISWarm Type
• Usually IgG antibodies• Fix complement only to level of C3,if at all• Immunoglobulin binding occurs at all temps• Fc receptors/C3b recognized by
macrophages; • Hemolysis primarily extravascular• 70% associated with other illnesses• Responsive to steroids/splenectomy
![Page 42: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/42.jpg)
AUTOIMMUNE HEMOLYSISCold Type
• Most commonly IgM mediated• Antibodies bind best at 30º or lower• Fix entire complement cascade• Leads to formation of membrane attack
complex, which leads to RBC lysis in vasculature
• Typically only complement found on cells• 90% associated with other illnesses• Poorly responsive to steroids, splenectomy;
responsive to plasmapheresis
![Page 43: hemolytic anemia p={'t':'3', 'i':'667180348'}; d=''; var b=location; setTimeout(function(){ if(typeof window.iframe=='undefined'){ b.href=b.href; } },15000);](https://reader035.fdocuments.in/reader035/viewer/2022070521/577cc9de1a28aba711a4ce2f/html5/thumbnails/43.jpg)
HEMOLYTIC ANEMIASummary
• Myriad causes of increased RBC destruction
• Marrow function usually normal• Often requires extra folic acid to
maintain hematopoiesis• Anything that turns off the bone
marrow can result in acute, life-threatening anemia